11 – 20 of 27
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Ultrastructural evidence for self-replication of alzheimer-associated Aβ42 amyloid along the sides of fibrils
2020) In Proceedings of the National Academy of Sciences of the United States of America 117(21). p.11265-11273(
- Contribution to journal › Article
-
Mark
Outcome and characteristics of non-measurable myeloma : A cohort study with population-based data from the Swedish Myeloma Registry
(
- Contribution to journal › Article
-
Mark
Apolipoprotein A-I in glucose metabolism and amyloidosis
(
- Thesis › Doctoral thesis (compilation)
- 2018
-
Mark
Effects of iron on the aggregation propensity of the N-terminal fibrillogenic polypeptide of human apolipoprotein A-I
(
- Contribution to journal › Article
-
Mark
High-efficient bacterial production of human ApoA-I amyloidogenic variants
(
- Contribution to journal › Article
- 2013
-
Mark
Molecular Mechanisms in Amyloid Disorders. Novel Treatment Options in Hereditary Cystatin C Amyloid Angiopathy.
(
- Thesis › Doctoral thesis (compilation)
- 2009
-
Mark
UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)
(
- Contribution to journal › Article
- 2007
-
Mark
Domain swapping as a molecular mechanism in amyloidosis
(
- Thesis › Doctoral thesis (compilation)
- 2006
-
Mark
Checking the conformational stability of cystatin C and its L68Q variant by molecular dynamics studies: Why is the L68Q variant amyloidogenic?
(
- Contribution to journal › Article
- 2000
-
Mark
L68Q cystatin C. Expression, cellular transport and turnover of the cystatin C variant forming amyloid in patients with Hereditary Cystatin C Amyloid Angiopathy (HCCAA)
2000)(
- Thesis › Doctoral thesis (compilation)